Protagonist Therapeutics, Inc. · NASDAQ:PTGX

Deep Track Capital, LP reported a 5.29% stake in Protagonist Therapeutics, Inc. (Schedule 13G)

Event Apr 3, 2025 · Filed Apr 10, 2025

Deep Track Capital, LP reported a 5.29% stake in Protagonist Therapeutics, Inc., 3,250,000 shares, as a passive investor on Apr 3, 2025. Filed Apr 10, 2025 (Schedule 13G).

Stake
5.29%
Shares
3,250,000
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP5.29%3,250,000
Deep Track Biotechnology Master Fund, Ltd.5.29%3,250,000
David Kroin5.29%3,250,000

Source

View original at SEC

Related